Comparing Misoprostol and Pitocin for Labor Induction in Obese Pregnant Patients
This study is comparing two different medications, Misoprostol and Pitocin, to see which is more effective at starting labor in pregnant patients who have a Body Mass Index (BMI) of 30 or higher. You could be eligible to join if you are pregnant, 18 years or older, and coming to the hospital for labor induction with a BMI of 30 or more. The study wants to find out if one medication helps you deliver your baby faster than the other. The current status of this study is unclear, but it aims to include 281 participants.
- Study design
- This is a randomized controlled trial, meaning participants will be randomly assigned to receive either Misoprostol or Pitocin. The study plans to enroll 281 women.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary outcome measured is the time from the start of induction until delivery, so follow-up would be until delivery.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Different Medications to Induce Labor
At a glance
Conditions
Where it's being run
2 sites across 1 statesStudy leadership
- Nicola F Tavella, MPH · STUDY_DIRECTOR · Icahn School of Medicine at Mount Sinai
- Angela Bianco, MD · PRINCIPAL_INVESTIGATOR · Icahn School of Medicine at Mount Sinai
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Time from induction to deliverystart of induction until delivery
Simple measure calculating time from start of induction until delivery of neonate.